Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Belatacept may be a promising treatment for alopecia areata.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Some gonadal hormone drugs can block filovirus entry into cells.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.